KREBS BIOCHEMICALS & INDUSTRIES Financial Statement Analysis
|
||
The Revenues of KREBS BIOCHEMICALS & INDUSTRIES have decreased by -3.28% YoY .
The Earnings Per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Annual Financial Results
[BOM: 524518|NSE : KREBSBIO]
Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹50 Cr | ₹52 Cr | ₹60 Cr | ₹54 Cr | ₹33 Cr |
Expenses | ₹59 Cr | ₹68 Cr | ₹94 Cr | ₹71 Cr | ₹52 Cr |
Operating Profit (Excl OI) | ₹-8.72 Cr | ₹-16 Cr | ₹-34 Cr | ₹-18 Cr | ₹-19 Cr |
Other Income | ₹0.45 Cr | ₹0.62 Cr | ₹1.16 Cr | ₹0.62 Cr | ₹0.37 Cr |
Interest | ₹4.69 Cr | ₹2.97 Cr | ₹5.39 Cr | ₹6.28 Cr | ₹6.00 Cr |
Depreciation | ₹6.77 Cr | ₹6.56 Cr | ₹6.30 Cr | ₹5.12 Cr | ₹4.68 Cr |
Profit Before Tax | ₹-20 Cr | ₹-25 Cr | ₹-45 Cr | ₹-28 Cr | ₹-29 Cr |
Profit After Tax | ₹-20 Cr | ₹-25 Cr | ₹-45 Cr | ₹-28 Cr | ₹-29 Cr |
Earnings Per Share (Rs) | ₹-9.15 | ₹-11.45 | ₹-20.65 | ₹-14.45 | ₹-16.04 |
PAT Margin (%) | -39.13 | -47.36 | -74.58 | -52.81 | -86.41 |
ROE(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ROCE(%) | -18.99 | -28.59 | -57.38 | -40.28 | -56.96 |
Total Debt/Equity(x) | -1.62 | -1.84 | -1.91 | -2.37 | -2.03 |
Key Financials |
||
Market Cap | : | ₹ 216.0 Cr |
Revenue (TTM) | : | ₹ 49.2 Cr |
Net Profit(TTM) | : | ₹ -24.5 Cr |
EPS (TTM) | : | ₹ -11.4 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
KREBS BIOCHEMICALS & INDUSTRIES | 1.9% | 5.3% | 38.8% |
SUN PHARMACEUTICAL INDUSTRIES | 0.6% | -4.6% | 20.7% |
CIPLA | -2.9% | -3.9% | 1.1% |
DR REDDYS LABORATORIES | 0.9% | -10.4% | 0.1% |
ZYDUS LIFESCIENCES | 0.9% | -0.3% | 27.9% |
DIVIS LABORATORIES | 9.8% | 4.5% | 64.7% |
MANKIND PHARMA | 1.9% | -13.7% | 24% |
TORRENT PHARMACEUTICALS | -4.4% | -6.3% | 17.5% |
LUPIN | 5.1% | -2.9% | 34.2% |
KREBS BIOCHEMICALS & INDUSTRIES Revenues
[BOM: 524518|NSE : KREBSBIO]
Y-o-Y | -3.28 % |
5 Yr CAGR | 10.84 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹50 Cr | -3.28 | |
Mar2023 | ₹52 Cr | -12.68 | |
Mar2022 | ₹60 Cr | 11.18 | |
Mar2021 | ₹54 Cr | 60.72 | |
Mar2020 | ₹33 Cr | - |
KREBS BIOCHEMICALS & INDUSTRIES Operating Profit
[BOM: 524518|NSE : KREBSBIO]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-8.72 Cr | Negative | |
Mar2023 | ₹-16 Cr | Negative | |
Mar2022 | ₹-34 Cr | Negative | |
Mar2021 | ₹-18 Cr | Negative | |
Mar2020 | ₹-19 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | -17.3% | Negative | |
Mar2023 | -30.27% | Negative | |
Mar2022 | -56.94% | Negative | |
Mar2021 | -32.73% | Negative | |
Mar2020 | -55.53% | - |
KREBS BIOCHEMICALS & INDUSTRIES Profit After Tax
[BOM: 524518|NSE : KREBSBIO]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹-20 Cr | Negative | |
Mar2023 | ₹-25 Cr | Negative | |
Mar2022 | ₹-45 Cr | Negative | |
Mar2021 | ₹-28 Cr | Negative | |
Mar2020 | ₹-29 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | -39.13 % | Negative | |
Mar2023 | -47.36 % | Negative | |
Mar2022 | -74.58 % | Negative | |
Mar2021 | -52.81 % | Negative | |
Mar2020 | -86.41 % | - |
KREBS BIOCHEMICALS & INDUSTRIES Earnings Per Share (EPS)
[BOM: 524518|NSE : KREBSBIO]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹-9.15 | Negative | |
Mar2023 | ₹-11 | Negative | |
Mar2022 | ₹-21 | Negative | |
Mar2021 | ₹-14 | Negative | |
Mar2020 | ₹-16 | - |
KREBS BIOCHEMICALS & INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 524518|NSE : KREBSBIO]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | -18.99% | Negative | |
Mar2023 | -28.59% | Negative | |
Mar2022 | -57.38% | Negative | |
Mar2021 | -40.28% | Negative | |
Mar2020 | -56.96% | - |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
Current Share Price | : | ₹100.0 |
Current MarketCap | : | ₹ 216.0 Cr |
Updated EOD on | : | Feb 05,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KREBS BIOCHEMICALS & INDUSTRIES | 1.9% |
5.3% |
38.8% |
SENSEX | 2% |
0.1% |
8.6% |
KREBS BIOCHEMICALS & INDUSTRIES related INDICES
You may also like the below Video Courses
FAQ about KREBS BIOCHEMICALS & INDUSTRIES Financials
How the annual revenues of KREBS BIOCHEMICALS & INDUSTRIES have changed ?
The Revenues of KREBS BIOCHEMICALS & INDUSTRIES have decreased by -3.28% YoY .
How the Earnings per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES have changed?
The Earnings Per Share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs